133 related articles for article (PubMed ID: 32378183)
21. Women treated with breast conserving surgery do better than those with mastectomy independent of detection mode, prognostic and predictive tumor characteristics.
Hofvind S; Holen Å; Aas T; Roman M; Sebuødegård S; Akslen LA
Eur J Surg Oncol; 2015 Oct; 41(10):1417-22. PubMed ID: 26253193
[TBL] [Abstract][Full Text] [Related]
22. Population-Based Study on Cancer Subtypes, Guideline-Concordant Adjuvant Therapy, and Survival Among Women With Stage I-III Breast Cancer.
Hsieh MC; Zhang L; Wu XC; Davidson MB; Loch M; Chen VW
J Natl Compr Canc Netw; 2019 Jun; 17(6):676-686. PubMed ID: 31200362
[TBL] [Abstract][Full Text] [Related]
23. Relation of body mass index to tumor markers and survival among young women with invasive ductal breast carcinoma.
Daling JR; Malone KE; Doody DR; Johnson LG; Gralow JR; Porter PL
Cancer; 2001 Aug; 92(4):720-9. PubMed ID: 11550140
[TBL] [Abstract][Full Text] [Related]
24. Breast cancer diagnosis and mortality by tumor stage and migration background in a nationwide cohort study in Sweden.
Abdoli G; Bottai M; Sandelin K; Moradi T
Breast; 2017 Feb; 31():57-65. PubMed ID: 27810701
[TBL] [Abstract][Full Text] [Related]
25. Risk of mortality of node-negative, ER/PR/HER2 breast cancer subtypes in T1, T2, and T3 tumors.
Parise CA; Caggiano V
Breast Cancer Res Treat; 2017 Oct; 165(3):743-750. PubMed ID: 28689363
[TBL] [Abstract][Full Text] [Related]
26. Association of Low Tumor Endothelial Cell pY397-Focal Adhesion Kinase Expression With Survival in Patients With Neoadjuvant-Treated Locally Advanced Breast Cancer.
Roy-Luzarraga M; Abdel-Fatah T; Reynolds LE; Clear A; Taylor JG; Gribben JG; Chan S; Jones L; Hodivala-Dilke K
JAMA Netw Open; 2020 Oct; 3(10):e2019304. PubMed ID: 33107920
[TBL] [Abstract][Full Text] [Related]
27. The prognostic effect of estrogen receptor status differs for younger versus older breast cancer patients.
Sopik V; Sun P; Narod SA
Breast Cancer Res Treat; 2017 Sep; 165(2):391-402. PubMed ID: 28601929
[TBL] [Abstract][Full Text] [Related]
28. No association between low-dose aspirin use and breast cancer outcomes overall: a Swedish population-based study.
Frisk G; Ekberg S; Lidbrink E; Eloranta S; Sund M; Fredriksson I; Lambe M; Smedby KE
Breast Cancer Res; 2018 Nov; 20(1):142. PubMed ID: 30458873
[TBL] [Abstract][Full Text] [Related]
29. Risk factors for subsequent invasive breast cancer and breast cancer death after ductal carcinoma in situ: a population-based case-control study in Sweden.
Wärnberg F; Bergh J; Zack M; Holmberg L
Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):495-9. PubMed ID: 11352860
[TBL] [Abstract][Full Text] [Related]
30. Predictors of ovarian cancer survival: a population-based prospective study in Sweden.
Yang L; Klint A; Lambe M; Bellocco R; Riman T; Bergfeldt K; Persson I; Weiderpass E
Int J Cancer; 2008 Aug; 123(3):672-9. PubMed ID: 18498135
[TBL] [Abstract][Full Text] [Related]
31. Determination of GP88 (progranulin) expression in breast tumor biopsies improves the risk predictive value of the Nottingham Prognostic Index.
Serrero G; Hawkins DM; Bejarano PA; Ioffe O; Tkaczuk KR; Elliott RE; Head JF; Phillips J; Godwin AK; Weaver J; Hicks D; Yue B
Diagn Pathol; 2016 Aug; 11(1):71. PubMed ID: 27501955
[TBL] [Abstract][Full Text] [Related]
32. Prospective study of serum selenium levels and incident esophageal and gastric cancers.
Mark SD; Qiao YL; Dawsey SM; Wu YP; Katki H; Gunter EW; Fraumeni JF; Blot WJ; Dong ZW; Taylor PR
J Natl Cancer Inst; 2000 Nov; 92(21):1753-63. PubMed ID: 11058618
[TBL] [Abstract][Full Text] [Related]
33. Androgen receptor expression and breast cancer mortality in a population-based prospective cohort.
Elebro K; Bendahl PO; Jernström H; Borgquist S
Breast Cancer Res Treat; 2017 Oct; 165(3):645-657. PubMed ID: 28643022
[TBL] [Abstract][Full Text] [Related]
34. Diagnostic and prognostic potential of serum angiopoietin-2 expression in human breast cancer.
Li P; He Q; Luo C; Qian L
Int J Clin Exp Pathol; 2015; 8(1):660-4. PubMed ID: 25755760
[TBL] [Abstract][Full Text] [Related]
35. Breast cancer risk prediction models and subsequent tumor characteristics.
Miller EA; Pinsky PF; Heckman-Stoddard BM; Minasian LM
Breast Cancer; 2020 Jul; 27(4):662-669. PubMed ID: 32056079
[TBL] [Abstract][Full Text] [Related]
36. Risk for distant recurrence of breast cancer detected by mammography screening or other methods.
Joensuu H; Lehtimäki T; Holli K; Elomaa L; Turpeenniemi-Hujanen T; Kataja V; Anttila A; Lundin M; Isola J; Lundin J
JAMA; 2004 Sep; 292(9):1064-73. PubMed ID: 15339900
[TBL] [Abstract][Full Text] [Related]
37. Prognostic significance of interferon regulating factor 4 (IRF4) in node-negative breast cancer.
Heimes AS; Madjar K; Edlund K; Battista MJ; Almstedt K; Gebhard S; Foersch S; Rahnenführer J; Brenner W; Hasenburg A; Hengstler JG; Schmidt M
J Cancer Res Clin Oncol; 2017 Jul; 143(7):1123-1131. PubMed ID: 28251349
[TBL] [Abstract][Full Text] [Related]
38. The relationship of dietary selenium and breast cancer.
McConnell KP; Jager RM; Bland KI; Blotcky AJ
J Surg Oncol; 1980; 15(1):67-70. PubMed ID: 6252392
[TBL] [Abstract][Full Text] [Related]
39. The relation of reproductive factors to mortality from breast cancer.
Daling JR; Malone KE; Doody DR; Anderson BO; Porter PL
Cancer Epidemiol Biomarkers Prev; 2002 Mar; 11(3):235-41. PubMed ID: 11895871
[TBL] [Abstract][Full Text] [Related]
40. Young adult breast cancer patients have a poor prognosis independent of prognostic clinicopathological factors: a study from the Japanese Breast Cancer Registry.
Kataoka A; Iwamoto T; Tokunaga E; Tomotaki A; Kumamaru H; Miyata H; Niikura N; Kawai M; Anan K; Hayashi N; Masuda S; Tsugawa K; Aogi K; Ishida T; Masuoka H; Iijima K; Kinoshita T; Nakamura S; Tokuda Y
Breast Cancer Res Treat; 2016 Nov; 160(1):163-172. PubMed ID: 27647460
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
